ARCHIVES

RFAs: Patient Outcomes “5-A-Day” Program

This article is from The Cancer Letter archive.

Vol. 18 No. 15 | April 10, 1992

Download PDF Visit The Full Archive

Related Articles

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay

June 3, 1977

NIAID, Vaccine Center Begin Phase I Trial Of AIDS Vaccine.

October 12, 2001

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989